Rankings
▼
Calendar
SMMT Q4 2025 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$4,355
Operating Income
$57M
Net Income
-$219M
EPS (Diluted)
$-0.29
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$100M
Free Cash Flow
-$100M
Stock-Based Comp.
$243M
Balance Sheet
Total Assets
$751M
Total Liabilities
$92M
Stockholders' Equity
$659M
Cash & Equivalents
$225M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$4,355
-$15M
+100.0%
Operating Income
$57M
-$66M
+187.3%
Net Income
-$219M
-$61M
-258.1%
← FY 2025
All Quarters